ADVOCATE | CONNECT | INSPIRE

GEORGIA BIO'S MISSION

is to advance the growth of Georgia’s life sciences industry and foster strategic
partnerships that can create a healthier world

Make Your Voice Be Heard

Georgia Bio is your advocate on the state and federal level to ensure the innovation economy is thriving.

What Interests You?

Ag/Industrial/ Environmental Biotech

Biopharma

Digital Health

Education & Workforce Development

Emerging Companies

Global & Public Health

MedTech & Devices

Students & Young Professionals

Accelerating Life Sciences Across Georgia

Georgia Bio is an independent, non-profit 501(c)(3) trade association whose mission is to advance the growth of Georgia’s life sciences industry and foster strategic partnerships that can create a healthier world. To accomplish this mission, Georgia Bio works on behalf of 200 member organizations to drive public policy, build a network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.

Champion Members

ONE VOICE

Advancing Georgia's Life Sciences IndustrySharing New KnowledgeGrowing the Bottom Line - and the Bioeconomy

Upcoming Events

Biotech and Brews

Jul 15, 2022 3:00PM—5:00PM

Creature Comforts Downtown Taproom 271 W Hancock Ave, Athens, GA 30601

Summer BioBash with Georgia Bio, GIPA, & Women In Bio

Aug 23, 2022 5:00PM—8:00PM

Round Trip Brewing Company 1279 Seaboard Industrial Blvd NW Atlanta, GA 30318

2022 Georgia Bio Patient Advocacy Summit

Aug 23, 2022 11:00AM—1:00PM

Virtual Event

View Latest News

Aruna Bio Announces Issuance of a New Composition Of Matter Patent Covering Neural Exosomes in Japan

June 14, 2022

Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced…

Read More

Augusta University to launch new School of Public Health

May 26, 2022

Augusta University President Brooks A. Keel, PhD, has announced the creation of the School of Public Health, which will be a…

Read More

GeoVax Labs updates investors on its COVID-19 vaccine and cancer immunotherapy clinical trials

May 13, 2022

GeoVax Labs CEO David Dodd talks to Proactive about its three separate ongoing Phase II clinical trials in developing a…

Read More